Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04588233 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Melatonin Adolescent Research Study

Study acronym: MARS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Primary and study completion pushed from May 2026 to May 2027v10
  2. Minor Primary and study completion dates: Dec 2025 to May 2026v9
  3. Minor Re-verified, no change to tracked fieldsv8
  4. Notable Primary and study completion dates: Dec 2024 to Dec 2025v7
  5. Notable Primary and study completion dates: Aug 2023 to Dec 2024v6
Show 4 earlier versionsHide 4 earlier versions
  1. Minor Primary and study completion dates: Apr 2023 to Aug 2023v5
  2. Minor Re-verified, no change to tracked fieldsv4
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 2
    • Start date changed from estimate of Aug 2021 to Sep 15, 2021
    v3
  4. Notable Start date: Apr 2021 to Aug 2021v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The present study will use a within-person, randomized cross-over experimental design to test the effects of exogenous melatonin supplementation on the sleep and daytime functioning of typically developing adolescents with short or disrupted sleep of behavioral origins (i.e., difficulty falling asleep, staying asleep, or premature waking resulting in short or disrupted sleep not attributed to an organic sleep condition).
Trial Details
NCT Number NCT04588233
Lead Sponsor Loma Linda University
Conditions
(from sponsor)
Sleep Disorders in Children
Related terms Parasomnias
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov